Skip to main content
Signal8

Minerva Surgical, Inc. (UTRS)

Sector: Medical - Devices

Industry: Medical - Devices

Minerva Surgical, Inc. logo

Minerva Surgical, Inc.

OTC:UTRSHealthcare
CLOSED
Mkt Cap-
EV-
Float961K
O/S8.88M
VOL260 sh
$ Vol$0
RVOL1.00×
Inst Own-
SI<0.1%
Net Cash/Sh-
EarningsNov 17 · Today
Dilution
Historical Data
DateOpenHighLowCloseVolume
Nov 9, 20260.00010.00010.00010.0001260
Oct 15, 20260.00010.00010.00010.0001278
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
Not available
Ratings Distribution
BUY
3
HOLD
0
SELL
1
TOTAL4
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(0)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Sources: 13D/13G
About

Minerva Surgical, Inc. functions as a commercial-stage medical technology enterprise, specializing in the creation, production, and distribution of innovative, minimally invasive solutions tailored to address the uterine healthcare needs of women throughout the United States. Their suite of offerings features advanced endometrial ablation systems, including the Minerva ES and Genesys HTA. They also provide the Symphion Tissue Removal System, a sophisticated, minimally invasive device for uterine tissue removal that uniquely integrates bladeless tissue resection, coagulation capabilities, continuous visualization during procedures, and precise intrauterine pressure monitoring.

Additionally, the Resectr Tissue Resection Device is a handheld surgical tool engineered for the hysteroscopic removal and diagnostic evaluation of endometrial polyps. These specialized instruments are utilized by obstetrician-gynecologists across a variety of clinical settings, such as hospitals, outpatient ambulatory surgical centers, and private physician practices.

The company was founded in 2008 and is headquartered in Santa Clara, California.

Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.

SectorHealthcare
IndustryMedical - Healthcare Information Services
ExchangeOTC
CountryUSUS
IPO DateOct 22, 2021
Shares Outstanding8.88M
Authorized Shares
Float961,311
52-Week Range
Volume
Average Daily Volume260

30d Avg

260

60d Avg

321

90d Avg

321

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...